Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
Here, the authors identify B lymphocyte antigen CD20 as a marker for HIV-infected T cells and provide evidence for the potential use of anti-CD20 antibodies in combination with latency reversing agents for depletion of viral reactivated CD4 T cells in patients on antiretroviral therapy.
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/704040ec0d7d48cf90855591b8bb7358 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|